Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis
The aim of this study was to evaluate the efficacy of oral transmucosal (OTM) cannabidiol (CBD), in addition to a multimodal pharmacological treatment for chronic osteoarthritis-related pain in dogs. Twenty-one dogs were randomly divided into two groups: in group CBD (<i>n</i> = 9), OTM...
Main Authors: | Federica Alessandra Brioschi, Federica Di Cesare, Daniela Gioeni, Vanessa Rabbogliatti, Francesco Ferrari, Elisa Silvia D’Urso, Martina Amari, Giuliano Ravasio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/10/9/1505 |
Similar Items
-
Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen
by: Claudia Interlandi, et al.
Published: (2024-02-01) -
Oral Transmucosal or Intramuscular Administration of Dexmedetomidine–Methadone Combination in Dogs: Sedative and Physiological Effects
by: Daniela Gioeni, et al.
Published: (2020-11-01) -
Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
by: Giorgia della Rocca, et al.
Published: (2023-01-01) -
The application of oral transmucosal fentanyl for the treatment of breakthrough pain in cancer patients
by: D V Nevzorova, et al.
Published: (2017-06-01) -
Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies
by: Chanthawat Patikorn, et al.
Published: (2023-09-01)